Briefcases -- All Litigations -- FLUOROQUINOLONES MDL 2642
FLUOROQUINOLONES MDL 2642
Case Files
News
Chat
Easy Button
Committees

Categories

  1. MDL 2642 Link to US District Website for Fluorquinolones
  2. FLUOROQUINOLONES MDL 2642 Plaintiff Leadership Committee (PTO No. 4)
  3. FLUOROQUINOLONES MDL 2642 Plaintiff Fact Sheet (PTO No. 7)
  4. FLUOROQUINOLONE MDL 2642 CLIENT INTAKE TEMPLATES
  5. FLUOROQUINOLONES MDL 2642 Master Complaints and Fact Sheets
  6. Fluoroquinolones MDL 2642 FDA Safety Releases; Independent Research Studies and Data
  7. Fluoroquinolones MDL 2642 Case Update through Dec 1, 2016 from the Court
  8. Fluoroquinolones MDL 2642 PreTrial Orders
  9. Fluoroquinolones MDL 2642 Long Form Complaint Examples
  10. Fluoroquinolones MDL 2642 Transfer Motion
  11. CIPRO (Ciprofloxacin) FDA APPROVAL MATERIALS by Bayer Corporation 2004
  12. Fluoroquinolones MDL 2642 General Case Materials (Drug Data, FDA Recalls Etc)
  13. Fluoroquinolones MDL 2642 Initial Transfer Order
  14. MDL 2642 and MDL 1943 Important Info
  15. Judge Tunheim Practice Pointers and Preferences
  16. Judge Tunheim Contacts
  17. Levaquin FDA Approval History
  18. Avelox FDA Approval History
  19. Cipro FDA Approval History
  20. Fluoroquinolone MDL CTOs
  21. Fluoroquinolones MDL Motion To Form Steering Committee
  22. Fluoroquinlones Notices of Apperance Defense
  23. Floroquinolone MDL Notice of Apperance Plaintiffs
  24. Case of Interest Gratteau v J & J Motion to Vacate and Remand
  25. Case of Interest Shanga Johnson vs Johnson and Johnson
  26. Floroquinolones FDA Warning Recording
View All

Documents

  1. Fluoroquinolone MDL 2642 Pretrial Order No. 7 Plaintiff Fact Sheet Template 04-26-2016
  2. Fluoroquinolone MDL 2642 Pretrial Order 4 Plaintiff Leadership Committee 03-17-2016.pdf
  3. Fluoroquinolone MDL Plaintiffs 2nd Amended Master Complaint as of 08-12-2016
  4. MDL 2642 Doc 1-10 Complaint J and J et.al Levaquin.docx
  5. FLUOROQUINOLONE BLANK INTAKE II TEMPLATE FQAD Phase One Intake II.docx
  6. Fluoroquinolone MDL 2642 Pretrial Order 7 Plaintiff Fact Sheet Template 04-26-2016.pdf
  7. PTO Pleadings Order for Creation of Master Pleadings.pdf
  8. MDL 2642 and MDL 1943 Important Info.docx
  9. Fluoroquinolone MDL 2642 Pretrial Order 10 Defendant Fact Sheet Template 08-01-2016
  10. FLUORQUINOLONE BLANK INTAKE TEMPLATE Associated Aortic Disorder Phase One Intake.docx
  11. Fluoroquinolone MDL 2642 Defendant Fact Sheet Template 08-01-2016 (From PTO No. 10)
  12. Floroquinolones MDL 2642 Protective Order.pdf
  13. Floroquinolones MDL 2642 PTO 1 Procedures.pdf
  14. MDL 2642 Doc 58 Initial Transfer Order.pdf
  15. MDL 2642 List of Fluroroquinolones FDA.pdf
  16. Johnson_v_Johnson_&_Johnson Defedants Breif in Support.pdf
  17. Fluoroquinolone MDL 2642 Pretrial Order 7 Plaintiff Fact Sheet 04-26-2016
  18. Floroquinolones MDL 2642 Plaintiff Fact Sheet (Template) 04-26-2016 (From PTO No. 7)
  19. Fluoroquinolone MDL 2642 Pretrial Order 10 Defendant Fact Sheet 08-01-2016
  20. Fluoroquinolones MDL 2642 BMJ Research Study Fluoroquinolones and Collagen Associated Severe Adverse Events 10-28-2015.pdf
  21. Fluoroquinolones MDL 2642 FDA Drug Safety Announcement August 2013.pdf
  22. Fluoroquinolones MDL 2642 FDA Drug Safety Media Data.pdf
  23. Fluoroquinolones MDL 2642 FDA Drug Safety Media Data.Re Flouroquinolone -7-16-2016.docx
  24. Fluoroquinolones MDL 2642 Medline Aortic Dissection Data Sheet.docx
  25. FDA Audio Recording Fluoroquinolones Warning.mp4
  26. Fluoroquinolone FDA Safety Announcements 08 15 2013
  27. FDA Podcast.pdf
  28. Facts About Fluoroquinolones
  29. Fluoroquinlones data.pdf
  30. MDL 2642 List of Fluoroquinolones FDA.pdf
  31. Floroquinolones MDL 2642 PTO 2 Service of Process.pdf
  32. Floroquinolones MDL 2642 Master Pleadings PTO 3.pdf
  33. Floroquinolones MDL 2642 PTO 4 Plaintiffs Leadership and Steering Committee.pdf
  34. Floroquinolones MDL 2642 PTO 5 Case Management Plan.pdf
  35. Floroquinolones MDL 2642 PTO 6 Preservation Order.pdf
  36. Floroquinolones MDL 2642 PTO 7 Plaintiff Fact Sheet.pdf
  37. Floroquinolones MDL 2642 PTO-08 Consent Order ESI.pdf
  38. Floroquinolones MDL 2642 PTO-09-Deposition Protocol.pdf
  39. Floroquinolones MDL 2642 -PTO-10-Defendant Fact Sheet.pdf
  40. Fluoroquinolone MDL 2642 Pretrial Order 12 Common Benefit Oder 11-21-2016.pdf
  41. Jan 2016 Initial Status Conference Minutes.pdf
  42. Floroquinolones MDL 2642 Status Conference Feburary 2016.pdf
  43. Floroquinolones MDL 2642 March 2016 Status Conference.pdf
  44. Floroquinolones MDL 2642 April Status Conference.pdf
  45. Floroquinolones MDL 2642 May 2016 Status Conference.pdf
  46. Floroquinolones MDL 2642 Status Conference June 2016.pdf
  47. Floroquinolones MDL 2642 July 2016 Status Conference.pdf
  48. Fluoroquinolone MDL 2642 September 23, 2016 Status Conference Minutes.pdf
  49. Fluoroquinolone MDL 2642 October 24, 2016 Status Conference Minutes.pdf
  50. Fluoroquinolone MDL 2642 December 1, 2016 Status Conference Minutes.pdf
  51. MDL 2642 Doc 1-5 Complaint Janssen and J and J.docx
  52. MDL 2642 Doc 1-5 Complaint Janssen and J and J.pdf
  53. MDL 2642 Doc 1-6 Complaint Bayer et.al. Cipro.docx
  54. MDL 2642 Doc 1-6 Complaint Bayer et.al. Cipro.pdf
  55. MDL 2642 Doc 1-9 Complaint Bayer et.al. Cipro.pdf
  56. MDL 2642 Doc 1-10 Complaint J and J et.al Levaquin.pdf
  57. MDL 2642 Doc 1-12 Complaint J and J et.al Levaquin.docx
  58. MDL 2642 Doc 1-12 Complaint J and J et.al Levaquin.pdf
  59. MDL 2642 Doc 1-13 Complaint J and J et.al Levaquin.docx
  60. MDL 2642 Doc 1-13 Complaint J and J et.al Levaquin.pdf
  61. MDL 2642 Doc 1-14 Complaint J and J et.al Levaquin.docx
  62. MDL 2642 Doc 1-14 Complaint J and J et.al Levaquin.pdf
  63. MDL 2642 Doc 1-15 Complaint Bayer and Merck.docx
  64. MDL 2642 Doc 1-15 Complaint Bayer and Merck.pdf
  65. MDL 2642 Doc 1-16 Complaint J and J et.al. Levaquin.docx
  66. MDL 2642 Doc 1-16 Complaint J and J et.al. Levaquin.pdf
  67. MDL 2642 Doc 1-17 Complaint Bayer and Merck.docx
  68. MDL 2642 Doc 1-17 Complaint Bayer and Merck.pdf
  69. MDL 2642 Doc 1-18 Complaint Jannssen and Johnson and Johnson.docx
  70. MDL 2642 Doc 1-18 Complaint Jannssen and Johnson and Johnson.pdf
  71. MDL 2642 Doc 1-19 Complaint J and J et.al. Levaquin.docx
  72. MDL 2642 Doc 1-19 Complaint J and J et.al. Levaquin.pdf
  73. MDL 2642 Doc 1-20 Complaint J and J et.al. Levaquin.docx
  74. MDL 2642 Doc 1-20 Complaint J and J et.al. Levaquin.pdf
  75. MDL 2642 Doc 1-21 Complaint Johnson and Johnson and Janssen.docx
  76. MDL 2642 Doc 1-21 Complaint Johnson and Johnson and Janssen.pdf
  77. MDL 2642 Doc 1-22 Complaint Bayer et.al..docx
  78. MDL 2642 Doc 1-22 Complaint Bayer et.al..pdf
  79. MDL 2642 Doc 1-23 Complaint Janssen and Johnson and Johnson.docx
  80. MDL 2642 Doc 1-23 Complaint Janssen and Johnson and Johnson.pdf
  81. MDL 2642 Doc 1-24 Complaint Bayer et.al..docx
  82. MDL 2642 Doc 1-24 Complaint Bayer et.al..pdf
  83. MDL 2642 Doc 1-25 Complaint Bayer et. al..docx
  84. MDL 2642 Doc 1-25 Complaint Bayer et. al..pdf
  85. MDL 2642 Doc 1-26 Complaint Bayer et.al..pdf
  86. MDL 2642 Doc 1-27 Complaint Bayer and Merck Avelox.docx
  87. MDL 2642 Doc 1-27 Complaint Bayer and Merck Avelox.pdf
  88. MDL 2642 Doc 1-28 Complaint J and J et.al. Levaquin.docx
  89. MDL 2642 Doc 1-28 Complaint J and J et.al. Levaquin.pdf
  90. MDL 2642 Doc -17 Complaint Bayer et.al..docx
  91. MDL 2642 Doc -17 Complaint Bayer et.al..pdf
  92. MDL 2642 Doc 1-11 J and J et.al. Levaquin.docx
  93. MDL 2642 Doc 1-11 J and J et.al. Levaquin.docx
  94. MDL 2642 CTO 1.pdf
  95. MDL 2642 Brief Motion to Transfer.pdf
  96. Floroquinolones MDL 2642 CIPRO FDA Administrative Correspondence Documents.pdf
  97. Floroquinolones MDL 2642 CIPRO FDA Approval Bayer Directors Memo of September 2003.pdf
  98. Floroquinolones MDL 2642 CIPRO FDA Approval Chemistry Review.pdf
  99. Floroquinolones MDL 2642 CIPRO FDA Approval Clinical Pharmacology Review.pdf
  100. Floroquinolones MDL 2642 CIPRO FDA Approval Labelling Submission March 25, 2004.pdf
  101. Floroquinolones MDL 2642 CIPRO FDA Approval Medical Review Part I.pdf
  102. Floroquinolones MDL 2642 CIPRO FDA Approval Medical Review Part II.pdf
  103. Floroquinolones MDL 2642 CIPRO FDA Approval Medical Review Part III.pdf
  104. Floroquinolones MDL 2642 CIPRO FDA Approval Medical Review Part IV.pdf
  105. Floroquinolones MDL 2642 CIPRO FDA Approval Pharmacology Review.pdf
  106. Floroquinolones MDL 2642 CIPRO FDA Approval Statistical Review.pdf
  107. Fluoroquinolone MDL 2642 Pretrial Order 4 Plaintiff Leadership Committee 03-17-2016.pdf
  108. Fluoroquinolone MDL 2642 Pretrial Order 7 Plaintiff Fact Sheet Template 04-26-2016.pdf
  109. MDL 2642 Doc 58 Initial Transfer Order.pdf
  110. MDL 2642 CTO 1.pdf
  111. MDL 2642 Brief Motion to Transfer.pdf
  112. MDL 2642 Doc 1-2 Cert of Service.pdf
  113. MDL 2642 Doc 1-5 Complaint Janssen and J and J.pdf
  114. MDL 2642 Doc 1-6 Complaint Bayer et.al. Cipro.pdf
  115. MDL 2642 Doc -17 Complaint Bayer et.al..pdf
  116. MDL 2642 Doc 1-9 Complaint Bayer et.al. Cipro.pdf
  117. MDL 2642 Doc 1-10 Complaint J and J et.al Levaquin.pdf
  118. MDL 2642 Doc 1-11 J and J et.al. Levaquin.pdf
  119. MDL 2642 Doc 1-12 Complaint J and J et.al Levaquin.pdf
  120. MDL 2642 Doc 1-13 Complaint J and J et.al Levaquin.pdf
  121. MDL 2642 Doc 1-14 Complaint J and J et.al Levaquin.pdf
  122. MDL 2642 Doc 1-15 Complaint Bayer and Merck.pdf
  123. MDL 2642 Doc 1-16 Complaint J and J et.al. Levaquin.pdf
  124. MDL 2642 Doc 1-17 Complaint Bayer and Merck.pdf
  125. MDL 2642 Doc 1-18 Complaint Jannssen and Johnson and Johnson.pdf
  126. MDL 2642 Doc 1-19 Complaint J and J et.al. Levaquin.pdf
  127. MDL 2642 Doc 1-20 Complaint J and J et.al. Levaquin.pdf
  128. MDL 2642 Doc 1-21 Complaint Johnson and Johnson and Janssen.pdf
  129. MDL 2642 Doc 1-3 Statement of Oral Argument.pdf
  130. MDL 2642 Doc 1-4 Proof of Service.pdf
  131. MDL 2642 Doc 1-22 Complaint Bayer et.al..pdf
  132. MDL 2642 Doc 1-23 Complaint Janssen and Johnson and Johnson.pdf
  133. MDL 2642 Doc 1-24 Complaint Bayer et.al..pdf
  134. MDL 2642 Doc 1-25 Complaint Bayer et. al..pdf
  135. MDL 2642 Doc 1-26 Complaint Bayer et.al..pdf
  136. MDL 2642 Doc 1-27 Complaint Bayer and Merck Avelox.pdf
  137. MDL 2642 Doc 1-28 Complaint J and J et.al. Levaquin.pdf
  138. MDL 2642 Doc 1 Plaintiffs Motion for Transfer.pdf
  139. MDL 2642 Doc 100 CTO 9 Final.pdf
  140. MDL 2642 Doc 99 CTO 7 Final.pdf
  141. MDL 2642 Doc 65 Cert of Service all Defendants.pdf
  142. MDL 2642 29-1 Proof of Service.pdf
  143. 2015-06-17-Reply.pdf
  144. MDL 2642 The Honorable John R Tunhiem Contacts.pdf
  145. MDL 2642 Local Rules Transferee Court.pdf
  146. MDL 2642 Court Information.pdf
  147. MDL 2642 PTO 1.pdf
  148. MDL 2642 Doc 29-main Waiver Oral Argument.pdf
  149. MDL 2642 Associated Cases.pdf
  150. Judge John Tunhiem Court Contacts and Info.pdf
  151. Fluoroquinolones.pdf
  152. Fluroroquinolones Use Data.pdf
  153. FDA Safety Annoucements 08152013.pdf
  154. Facts About Fluroroquinolones.pdf
  155. Fluoroquinlones data.pdf
  156. Pacer Changes.docx
  157. F luoroquinolone FDA Safety Announcements 08 15 2013.pdf
  158. FDA Podcast.pdf
  159. MDL 2642 Doc 1-5 Complaint Janssen and J and J.docx
  160. MDL 2642 Doc 1-18 Complaint Jannssen and Johnson and Johnson.docx
  161. MDL 2642 Doc 1-21 Complaint Johnson and Johnson and Janssen.docx
  162. MDL 2642 Doc 1-22 Complaint Bayer et.al..docx
  163. MDL 2642 Doc 1-23 Complaint Janssen and Johnson and Johnson.docx
  164. MDL 2642 Doc 1-10 Complaint J and J et.al Levaquin.docx
  165. MDL 2642 Doc 1-9 Complaint Bayer et.al. Cipro.docx
  166. MDL 2642 Doc 1-11 J and J et.al. Levaquin.docx
  167. MDL 2642 Doc 1-12 Complaint J and J et.al Levaquin.docx
  168. MDL 2642 Doc 1-13 Complaint J and J et.al Levaquin.docx
  169. MDL 2642 Doc 1-14 Complaint J and J et.al Levaquin.docx
  170. MDL 2642 Doc 1-16 Complaint J and J et.al. Levaquin.docx
  171. MDL 2642 Doc 1-28 Complaint J and J et.al. Levaquin.docx
  172. MDL 2642 Doc 1-15 Complaint Bayer and Merck.docx
  173. MDL 2642 Doc 1-19 Complaint J and J et.al. Levaquin.docx
  174. MDL 2642 Doc 1-27 Complaint Bayer and Merck Avelox.docx
  175. MDL 2642 Doc 1-24 Complaint Bayer et.al..docx
  176. MDL 2642 Doc 1-6 Complaint Bayer et.al. Cipro.docx
  177. MDL 2642 Doc -17 Complaint Bayer et.al..docx
  178. MDL 2642 Doc 1-20 Complaint J and J et.al. Levaquin.docx
  179. MDL 2642 Doc 1-17 Complaint Bayer and Merck.docx
  180. MDL 2642 Doc 1-25 Complaint Bayer et. al..docx
  181. MDL 2642 Levaquin Lead Counsel Defense Before JPML.pdf
  182. Letter to District Judge Requesting Status Conference.pdf
  183. MDL 2642 Doc 58 Initial Transfer Order.pdf
  184. Judge Tunheim Practice Pointers and Preferences.pdf
  185. Judge Tunheim Contacts
  186. Avelox FDA Approval History
  187. Avelox FDA Approval History
  188. Avelox FDA Approval History
  189. Flo CTO 1.pdf
  190. Fluoroquinolone CTO 24.pdf
  191. Fluoroquinolone CTO 24 Motion to Vacate Ex.pdf
  192. Fluoroquinolone CTO 24 Schedule of Actions.pdf
  193. Fluoroquinolone Motion to Vacate CTO 24.pdf
  194. Fluoroquinolone Motion to Vacate CTO 24 EX.pdf
  195. Fluoroquinolone Motion to Vacate CTO Superior Court Complaint.pdf
  196. Fluoroquinolone Orginal Complaint CTO 24.pdf
  197. Fluoroquinolone Plaintiffs Notice of Motion to Remand CTO 24.pdf
  198. Flurorquinolone Single Plaintiffs Motion to Vacate CTO.pdf
  199. Flo CTO 2.pdf
  200. Flo CTO 3.pdf
  201. Flo CTO 4.pdf
  202. Flo CTO 5.pdf
  203. Flo CTO 6.pdf
  204. Flo CTO 7.pdf
  205. FLO CTO 8.pdf
  206. Flo CTO 10.pdf
  207. FLO CTO 11.pdf
  208. FLO CTO 12.pdf
  209. Flo CTO 13.pdf
  210. Flo CTO 14.pdf
  211. Flo CTO 15.pdf
  212. Flo CTO 16.pdf
  213. FLO CTO 17.pdf
  214. Flo CTO 18.pdf
  215. FLO CTO 19.pdf
  216. Flo CTO 20.pdf
  217. Flo CTO 21.pdf
  218. FlO CTO 22.pdf
  219. Flo CTO 23.pdf
  220. Flo CTO 25.pdf
  221. Flo Motion to Appoint Steering Committee.pdf
  222. Flo Notice of Appear Defense Andrew Solow Kaye Scholer LLP.pdf
  223. Flo Notice of Appear Defense Arthur Brown Kaye Scholer.pdf
  224. Flo Notice of Appear Defense Cicely R Militch Faegre Baker Daniels LLP.pdf
  225. Flo Notice of Appear Defense Lori Leskin Kaye Scholer LLP.pdf
  226. Flo Notice of Appear Defense Martin Chester Faegre Baker Daniels LLP.pdf
  227. Flo Notice of Appearance Defense John D Winter.pdf
  228. Notice of Appear Defense Joseph M Price Fagre Baker Daniels LLP.pdf
  229. Flo Notice of Appear Bill Robins Heard Robins LLC.pdf
  230. Flo Notice of Appear Katie E Griffin Sill Law Group.pdf
  231. Flo Notice of Appear Plaintiff James F. Murdica Barnes & Thornburg LLP.pdf
  232. Flo Notice of Appear Plaintiff Ahmed Diab Gomez Trial Attorneys.pdf
  233. Flo Notice of Appear Plaintiff Bradley Johnston The Cavanagh Law Firm.pdf
  234. Flo Notice of Appear Plaintiff Olga Viner Heard Robins Cloud LLP.pdf
  235. Flo Plaintiffs Notice of Appear R Jason Richards AWKLO.pdf
  236. Fluoroquinolone CTO 24.pdf
  237. Fluoroquinolone CTO 24 Motion to Vacate Order.pdf
  238. Fluoroquinolone CTO 24 Schedule of Actions.pdf
  239. Fluoroquinolone Motion to Vacate CTO 24.pdf
  240. Fluoroquinolone Motion to Vacate CTO 24 EX.pdf
  241. Fluoroquinolone Motion to Vacate CTO Superior Court Complaint.pdf
  242. Fluoroquinolone Orginal Complaint CTO 24.pdf
  243. Fluoroquinolone Plaintiffs Notice of Motion to Remand CTO 24.pdf
  244. Flurorquinolone Single Plaintiffs Motion to Vacate CTO.pdf
  245. Flo Stipulated Ext of Time t Repond to Defense Motion to Dismiss.pdf
  246. Flo Stipulation to Ext of Time Defense Summary Judgement Motion.pdf
  247. Johnson_v_Johnson_&_Johnson CTO 3.pdf
  248. Johnson_v_Johnson_&_Johnson Defendants Motion to Dismiss SOL.pdf
View All

Discussion

    No Recent Messages
Add Comment